Why is there no direct conversion chart
Interestingly, a retrospective observational cohort study on 18 patients with PTC did identify two patients whose tumor volume increased following exposure to GLP-1RAs (43)
We also consider the effect of these molecules on other obesity-related complications [glycaemia in people with T2D and on liver fat content in people with MASLD/metabolic dysfunction-associated steatohepatitis (MASH, previously known as non-alcoholic steatohepatitis)] and we discuss the potential clinical implications and challenges that the new era in obesity pharmacotherapy will bring
Cardiovascular, metabolic, and safety outcomes with semaglutide by baseline age: post hoc analysis of SUSTAIN 6 and PIONEER 6
If you're navigating what insurance covers for GLP-1 weight loss medications, explore Maven Clinic's GLP-1 Care program
Retatrutide side effects at a glance Lilly reported the following TRIUMPH-1 results: Lilly said the dysesthesia and urinary-tract-infection events were generally mild to moderate, most resolved during treatment, and most participants continued taking retatrutide